- Home
- KGS vs DYN Comparison
KGS vs DYN Comparison
Compare KGS & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGS | DYN |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.1B |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KGS | DYN |
|---|---|---|
| Price | $75.73 | $18.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 14 |
| Target Price | ★ $57.17 | $37.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ 58.93 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,308,100,000.00 | N/A |
| Revenue This Year | $12.30 | N/A |
| Revenue Next Year | $7.96 | N/A |
| P/E Ratio | $375.50 | ★ N/A |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $30.06 | $8.25 |
| 52 Week High | $76.68 | $25.00 |
Technical Indicators
Market Signals| Indicator | KGS | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 79.56 | 52.18 |
| Support Level | $33.33 | $18.32 |
| Resistance Level | N/A | $19.52 |
| Average True Range (ATR) | 2.40 | 0.91 |
| MACD | 0.57 | 0.00 |
| Stochastic Oscillator | 92.24 | 63.07 |
Price Performance
Historical ComparisonAbout KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.